Bone Quality and Mechanical Properties in Osteoporosis Treatment

Osteoporosis arises from an imbalance between bone resorption and formation, leading to reduced bone mass, altered microarchitecture and increased fracture risk. Beyond bone mineral density, quality factors such as microstructural integrity, collagen–mineral interactions and nano­scale deformation govern mechanical performance and resilience under load. Treatments aiming to restore bone strength include antiresorptive agents, which slow osteoclast activity and preserve trabecular connectivity, and anabolic approaches, which stimulate new bone formation and improve collagen fibril properties. The interplay between altered porosity, microdamage accumulation and tissue mineralisation dictates whether treatment ultimately enhances toughness or merely increases stiffness. Advances in imaging, from micro­computed tomography to synchrotron diffraction, have revealed how therapies can differentially affect cortical versus trabecular compartments, influence microcrack repair and modify strain distribution across hierarchical length scales. Understanding these effects is crucial for optimising regimens that both strengthen bone and reduce fragility.

Research from Nature Portfolio

Recent studies have demonstrated that long-term bisphosphonate therapy, while effective at reducing trabecular perforations, can lead to the accumulation of microcracks and reductions in tensile strength and Young’s modulus at the tissue level. Synchrotron small-angle X-ray scattering has revealed that osteoporosis is characterised by decreased fibril deformation at low strain rates—correlating with fragility fractures—whereas bisphosphonate treatment partially restores nano-scale fibril plasticity and improves resistance under physiological loading. Additional work using diffraction-based techniques in fracture patients has shown that age-related fragility is linked to earlier disengagement between mineral and collagen phases, indicating that targeting collagen–mineral interactions may be essential to recover peak nano-scale strains and prevent low-energy fractures.

Bone Quality and Mechanical Properties in Osteoporosis Treatment publication trend

The graph below shows the total number of articles in bone quality and mechanical properties in osteoporosis treatment across all publications each year (not limited to Nature Index journals).

Technical terms

Bone mineral density (BMD): A measure of mineral content per unit volume of bone, often used as a surrogate for strength.

Trabecular architecture: The three-dimensional arrangement of spongy bone struts, which influences load distribution and fragility.

Cortical porosity: The presence of microscopic pores within dense cortical bone, affecting stiffness and toughness.

Microcrack: A very small fracture within bone tissue that may accumulate under suppressed remodelling and compromise structural integrity.

Young’s modulus: A parameter describing a material’s stiffness, defined as stress divided by strain in the elastic region.

Synchrotron small-angle X-ray scattering (SAXS): A high-resolution technique to assess nano-scale deformation and fibril mechanics under load.

Osseointegration: The process by which bone tissue bonds to an implant or scaffold, critical for implant stability in osteoporotic bone.

References

1. Enhancing bone regeneration and osseointegration using rhPTH(1-34) and dimeric R25CPTH(1-34) in an osteoporotic beagle model. eLife (2024).
2. Exercise for optimizing bone health after hormone-induced increases in bone stiffness. Frontiers in Endocrinology (2023).
3. Administration frequency as well as dosage of PTH are associated with development of cortical porosity in ovariectomized rats. Bone Research (2017).
4. Long-term effects of bisphosphonate therapy: perforations, microcracks and mechanical properties. Scientific Reports (2017).
5. Nanoscale mechanisms in age-related hip-fractures. Scientific Reports (2020).